Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,625 | $8,757 | $8,124 | $8,434 |
| % Growth | 9.9% | 7.8% | -3.7% | – |
| Cost of Goods Sold | $2,782 | $2,559 | $2,364 | $2,394 |
| Gross Profit | $6,843 | $6,198 | $5,760 | $6,040 |
| % Margin | 71.1% | 70.8% | 70.9% | 71.6% |
| R&D Expenses | $634 | $604 | $530 | $473 |
| G&A Expenses | $2,497 | $2,270 | $2,013 | $1,977 |
| SG&A Expenses | $3,283 | $2,895 | $2,531 | $2,492 |
| Sales & Mktg Exp. | $786 | $625 | $518 | $515 |
| Other Operating Expenses | $1,380 | $1,736 | $2,245 | $2,625 |
| Operating Expenses | $5,297 | $5,235 | $5,306 | $5,590 |
| Operating Income | $1,546 | $963 | $454 | $450 |
| % Margin | 16.1% | 11% | 5.6% | 5.3% |
| Other Income/Exp. Net | -$1,379 | -$1,353 | -$583 | -$1,474 |
| Pre-Tax Income | $167 | -$390 | -$129 | -$1,024 |
| Tax Expense | $239 | $221 | $83 | -$87 |
| Net Income | -$46 | -$592 | -$225 | -$948 |
| % Margin | -0.5% | -6.8% | -2.8% | -11.2% |
| EPS | -0.13 | -1.62 | -0.59 | -2.61 |
| % Growth | 92% | -174.6% | 77.4% | – |
| EPS Diluted | -0.13 | -1.62 | -0.59 | -2.61 |
| Weighted Avg Shares Out | 368 | 365 | 362 | 359 |
| Weighted Avg Shares Out Dil | 368 | 365 | 362 | 359 |
| Supplemental Information | – | – | – | – |
| Interest Income | $33 | $26 | $14 | $7 |
| Interest Expense | $1,388 | $1,328 | $1,464 | $1,426 |
| Depreciation & Amortization | $1,267 | $1,264 | $1,394 | $1,552 |
| EBITDA | $3,134 | $2,885 | $2,878 | $3,260 |
| % Margin | 32.6% | 32.9% | 35.4% | 38.7% |